share_log

Cantor Fitzgerald Reinstates Neutral on TherapeuticsMD, Announces $5 Price Target

Benzinga Real-time News ·  Jan 11, 2023 20:46

Cantor Fitzgerald analyst Louise Chen reinstates TherapeuticsMD (NASDAQ:TXMD) with a Neutral and announces $5 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment